Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis: Randomized Controlled Clinical Trial

NCT06543550 is registered in ClinicalTrials.gov with Bio Meds Pharmaceutica Ltda as lead sponsor.

NCT NCT06543550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06543550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis: Randomized Controlled Clinical Trial
Lead sponsor
Bio Meds Pharmaceutica Ltda
Phase
Phase 4
Overall status
Recruiting
Start date
July 30, 2024
Completion date
October 31, 2025
Enrollment
70 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis